CIK 0000926617
- Non-accelerated filer
- Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330595156
- Phone
- +1 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-08 | Strahley John Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +97,417 | 97,417 | ||
| 2026-06-16 | Strahley John Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2026-06-16 | Strahley John Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +75,000 | 75,000 |
Page 1 of 1 · 3 trades